The global medical device coating market is estimated to increase at a 7.8% CAGR from 2024-2031. The market was valued at USD XX billion in 2024, and it is expected to reach USD YY billion by 2031. North America dominated the market in 2024, owing to its well-established healthcare industry, widespread acceptance of modern medical equipment, and rising prevalence of chronic diseases. Factors driving market expansion include rising demand for minimally invasive surgical procedures, increasing frequency of hospital-acquired infections (HAIs), technical improvements in medical device coatings, and a growing elderly population.
Increasing demand for minimally invasive surgical procedures.
The rising need for minimally invasive surgical procedures is a significant driver of the medical device coating industry. Minimally invasive operations provide various advantages over typical open surgeries, including less discomfort, quicker recovery, shorter hospital stays, and a lower chance of complications. Coated medical devices, such as cardiovascular stents, catheters, and guidewires, are essential in minimally invasive treatments because they improve device performance, biocompatibility, and patient safety. The expanding use of minimally invasive procedures, combined with the increasing frequency of chronic diseases, is predicted to fuel demand for coated medical equipment.
The increasing prevalence of hospital-acquired infections (HAIs)
Another major driver of the medical device coating industry is the increasing occurrence of hospital-acquired infections (HAIs). HAIs are a prominent cause of morbidity and mortality in healthcare settings, resulting in higher expenses and longer hospital stays. Medical device coatings, particularly antimicrobial coatings, can help prevent bacteria and other germs from adhering and growing on device surfaces, lowering the risk of HAI. Antimicrobial coatings are predicted to be adopted in the healthcare business as infection control awareness grows and severe laws limit the usage of medical devices.
Stringent regulations and high development costs
Despite the various advantages of medical device coatings, tight regulatory constraints and expensive development costs may limit market expansion in some cases. Medical device coatings are subjected to rigorous testing and regulatory certification to assure their safety and effectiveness. Manufacturers may experience delays in product launches and increased development expenses due to the complex regulatory landscape and lengthy approval processes. Furthermore, the high cost of modern coating technologies, as well as the demand for skilled individuals, can make it difficult for small and medium-sized businesses to enter the market. However, the long-term benefits of coated medical devices, such as better patient outcomes and lower healthcare costs, are predicted to offset the initial outlay.
Antimicrobial coatings are likely to dominate the medical device coating market over the forecast period. Antimicrobial coatings are used to protect medical devices from the adherence and growth of bacteria, fungus, and other microbes, lowering the risk of device-associated infections. The rising prevalence of HAIs, combined with increased awareness of infection control and stringent laws controlling the use of medical equipment, is driving demand for antimicrobial coatings. Silver, copper, and zinc oxide are among the most often utilized antibacterial compounds in medical device coatings because to their broad-spectrum action and long-term effectiveness.
The cardiovascular devices section is predicted to have the fastest growth rate during the projection period. Cardiovascular devices such as stents, catheters, and heart valves are commonly used to treat a variety of cardiovascular ailments, including coronary artery disease, heart valve abnormalities, and peripheral arterial disease. The increased frequency of cardiovascular disorders, combined with the growing use of minimally invasive procedures, is pushing up demand for coated cardiovascular devices. Drug-eluting stents, which are coated with antiproliferative medicines to prevent restenosis, have transformed the treatment of coronary artery disease and are projected to fuel expansion in the cardiovascular devices market.
North America is predicted to dominate the medical device coating market over the forecast period.
The presence of a well-established healthcare industry, widespread acceptance of innovative medical devices, and rising frequency of chronic diseases are the primary drivers of market expansion in North America. The United States is the region's largest market for medical device coatings, because to the presence of major medical device makers, well-funded research institutions, and a strong emphasis on innovation and product development. The United States government's attempts to assist the development of sophisticated medical technology, such as the Medical Device User Fee Amendments (MDUFA), are accelerating market growth in the country.
Canada is another important market in the region, driven by an increasing frequency of chronic diseases, a growing senior population, and rising healthcare costs. The Canadian government's investments in healthcare infrastructure and R&D are expected to drive market growth in the country. The expanding acceptance of minimally invasive surgical treatments, as well as increased awareness of infection prevention, are all contributing to market expansion in Canada.
The medical device coating industry is extremely competitive, with multiple global and regional participants. To strengthen their market position, key corporations invest in product innovation, technical advancements, and strategic collaborations. Surmodics, Inc., Hydromer, Inc., Specialty Coating Systems, Inc., Biocoat, Inc., DSM Biomedical, Inc., Harland Medical Systems, Inc., AST Products, Inc., Precision Coating Company, Inc., Hemoteq AG, and N8 Medical, Inc. are among the market's top companies.
Surmodics, Inc. is a world leader in medical device coatings, providing a diverse range of coatings and surface modification technologies for a variety of medical devices such as cardiovascular, neurovascular, and orthopedic. The company's proprietary PhotoLink and SerioCoat coating platforms are widely used by medical device makers across the world. Hydromer, Inc. is another important competitor, with a strong presence in the hydrophilic coatings area and an emphasis on developing novel coating solutions for catheters, guidewires, and other medical devices.
Recently, the market has seen a number of product launches and significant collaborations. For example, in 2022, Biocoat, Inc. introduced the HYDAK UV coating, a revolutionary hydrophilic coating that can be applied to a variety of medical equipment via ultraviolet (UV) curing technology. In 2023, Hemoteq AG formed a strategic partnership with a leading cardiovascular device manufacturer to create drug-eluting balloon catheters for the treatment of peripheral artery disease.
With an increased emphasis on patient safety, rising demand for minimally invasive procedures, and technological improvements in coating technologies, the future of the medical device coating market is bright. However, tight regulatory constraints and hefty development costs may limit market expansion to a certain extent. The market is predicted to increase significantly in emerging nations, owing to rising healthcare expenditure, a thriving medical device sector, and an increasing prevalence of chronic diseases.
The medical device coating market is expected to rise steadily in the coming years, owing to rising demand for minimally invasive surgical procedures, an increasing prevalence of hospital-acquired infections, and advancements in coating technologies. The industry is very competitive, with top competitors focusing on product innovation, technological improvements, and strategic partnerships to obtain market share.
The antimicrobial coatings category is likely to dominate the market due to increased awareness of infection control and stringent laws governing the use of medical equipment. The cardiovascular devices segment is predicted to expand the fastest, owing to the rising frequency of cardiovascular disorders and the increased use of minimally invasive procedures.
However, market expansion may be hampered by the tight regulatory requirements and high development costs associated with medical device coatings. The creation of cost-effective and scalable coating technologies, as well as the implementation of expedited regulatory processes, will be critical to the widespread adoption of medical device coatings.
Overall, the medical device coating market offers considerable growth possibilities for companies that can effectively meet the changing needs of healthcare professionals and patients through novel coating solutions, technical advancements, and customer-centric services. The market is predicted to increase significantly in emerging nations, driven by rising healthcare spending and the expanding medical device industry.
Surmodics, Inc.
Hydromer, Inc.
Specialty Coating Systems, Inc.
Biocoat, Inc.
DSM Biomedical, Inc.
Harland Medical Systems, Inc.
AST Products, Inc.
Precision Coating Company, Inc.
Hemoteq AG
N8 Medical, Inc.
Sono-Tek Corp.
Covalon Technologies Ltd
In August 2022, Biocoat, Inc. launched the HYDAK® UV coating, a novel hydrophilic coating that can be applied to a wide range of medical devices using ultraviolet (UV) curing technology.
In January 2023, Hemoteq AG entered into a strategic collaboration with a leading cardiovascular device manufacturer to develop drug-eluting balloon catheters for the treatment of peripheral artery disease.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (KEY COMPANIES LIST BY COUNTRY) (PREMIUM)
5. COMPANY PROFILES
5.1. Surmodics, Inc.
5.2. Hydromer, Inc.
5.3. Specialty Coating Systems, Inc.
5.4. Biocoat, Inc.
5.5. DSM Biomedical, Inc.
5.6. Harland Medical Systems, Inc.
5.7. AST Products, Inc.
5.8. Precision Coating Company, Inc.
5.9. Hemoteq AG
5.10. N8 Medical, Inc.
5.11. Sono-Tek Corp.
5.12. Covalon Technologies Ltd. (*LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Increasing demand for minimally invasive procedures
6.1.2. Growing focus on antimicrobial coatings
6.1.3. Advancements in nanotechnology-based coatings
6.2. Market Drivers
6.2.1. Rising prevalence of hospital-acquired infections
6.2.2. Increasing healthcare expenditure on medical devices
6.2.3. Growing aging population and associated chronic diseases
6.3. Market Restraints
6.3.1. Stringent regulatory approval process for coated medical devices
6.3.2. High costs associated with advanced coating technologies
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Hydrophilic Coatings
7.2. Antimicrobial Coatings
7.3. Drug-Eluting Coatings
7.4. Anti-Thrombogenic Coatings
7.5. Others
8. BY MATERIAL (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
8.1. Fluoropolymers
8.2. Silicone
8.3. Parylene
8.4. Metals
8.5. Others
9. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Neurology
9.2. Orthopedics
9.3. General Surgery
9.4. Cardiovascular
9.5. Dentistry
9.6. Gynecology
9.7. Others
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
By Type:
Hydrophilic Coatings
Antimicrobial Coatings
Drug-Eluting Coatings
Anti-Thrombogenic Coatings
By Material:
Fluoropolymers
Silicone
Parylene
Metals
Others
By Application:
Cardiovascular Devices
Orthopedic Devices
Neurology Devices
General Surgery Devices
Others
By Region:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511